Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx.
Inherited disorders that are characterized by subcutaneous and submucosal EDEMA in the upper RESPIRATORY TRACT and GASTROINTESTINAL TRACT.
Forms of hereditary angioedema that occur due to mutations in the gene for COMPLEMENT C1 INHIBITOR PROTEIN. Type I hereditary angioedema is associated with reduced serum levels of complement C1 inhibitor protein. Type II hereditary angioedema is associated with the production of a non-functional complement C1 inhibitor protein.
An endogenous 105-kDa plasma glycoprotein produced primarily by the LIVER and MONOCYTES. It inhibits a broad spectrum of proteases, including the COMPLEMENT C1R and the COMPLEMENT C1S proteases of the CLASSICAL COMPLEMENT PATHWAY, and the MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES. C1-INH-deficient individuals suffer from HEREDITARY ANGIOEDEMA TYPES I AND II.
Serum proteins that inhibit, antagonize, or inactivate COMPLEMENT C1 or its subunits.
A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.
A form of hereditary angioedema that occurs in women and is precipitated or worsened by high ESTROGEN levels. It is associated with mutations in the gene for FACTOR XII that result in its increased activity.
A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders.
A synthetic steroid that has anabolic and androgenic properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1194)
Immunologically mediated adverse reactions to medicinal substances used legally or illegally.
Compounds that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host.
'Tongue diseases' is a broad term referring to various medical conditions that primarily affect the structure, function, or appearance of the tongue, including but not limited to infections, inflammatory conditions, autoimmune disorders, congenital abnormalities, and malignancies.
Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity.
An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.
A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter.
A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B.
Venoms from the superfamily Formicoidea, Ants. They may contain protein factors and toxins, histamine, enzymes, and alkaloids and are often allergenic or immunogenic.
General or unspecified diseases of the stomatognathic system, comprising the mouth, teeth, jaws, and pharynx.

Familial anglo-oedema--a particularly severe form. (1/263)

A case of hereditary angio-oedema is described together with the family history and manifestations in the father of the patient. The problems encountered in his management are discussed, including tracheostomy and genetic counselling.  (+info)

Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1. (2/263)

Different immunoglobulin preparations of human monoclonal IgM, normal human and rat IgG, as well as purified rabbit antibodies were treated by various methods, fragmentation, aggregation and complexing with antigen. The ability of the treated and untreated preparations to fix isolated human C1, to activate the classical complement pathway (to consume C4 in normal human serum) were compared. It was found that the different methods affected the conformation of the immunoglobulin molecules in different ways and induced changes to a greater or lesser extent in the two capacities of the preparations tested. In the case of the monoclonal IgM preparation a strong C1-fixation was observed without measurable complement activation. Other preparations, interfacially aggregated human IgG, BSA-anti-BSA and OA-anti-OA immune complexes had a very weak C1-fixing but a marked complement activating capacity. Some preparations, e.g. heat-aggregated IgG, both fixed and activated C1 effectively, aggregates with a complement-activating capacity without C1-fixing effect were separated by gel-filtration. It was demonstrated further, that at a given time only a part of the activated C1 molecules could be found fixed to the immunoglobulins, the other part was released into the fluid phase after activation. On the basis of the results of this and previous studies a hypothesis is proposed suggesting three possible results of the interaction between C1 and the different preparations: (1) firm fixation and activation; (2) binding not followed by activation and (3) a transient binding leading to activation. The possible application of this hypothesis for the interpretation of the results of the different methods for detecting immune complexes is discussed.  (+info)

Angioedema due to ACE inhibitors: increased risk in patients of African origin. (3/263)

AIMS: To determine patterns in presentation, risk factors, management and outcome of patients with ACE inhibitor associated angioedema in one British teaching hospital. METHODS: Cases of ACE inhibitor associated angioedema in patients presenting to the City Hospital, Birmingham between 1993 and 1999 were collected and entered prospectively onto a computerised register. RESULTS: A total of 20 cases (mean age 60 years, range 42-82 years) of ACE inhibitor associated angioedema were reported (11 female and 9 male) with 65% (n=13) of patients being black/Afro-Caribbean. In 70% of cases (n=14), angioedema occurred within 4 weeks of starting therapy, although three patients presented following long-term treatment (24-48 months). ACE inhibitors were continued in 50% (n=10) patients, despite at least one documented episode of angioedema. Admission to hospital was necessary in 40% (n=8) patients, with three of these admitted to the intensive care unit, and one of these died as a result of severe laryngeal obstruction. CONCLUSIONS: ACE inhibitor related angioedema is a serious and potentially fatal complication which is relatively rare in the general population, but is more common amongst black/Afro-Caribbean patients. ACE inhibitors are frequently continued following an episode of angioedema and it is important that these episodes are minimised by prompt cessation of the drug, careful patient counselling and heightened awareness in all clinicians who prescribe this common group of drugs.  (+info)

Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. (4/263)

AIMS: To explore drug exposure, frequency of adverse drug reactions (ADRs), types of ADRs, predisposing risk factors and ADR-related excess hospital stay in medical inpatients. METHODS: Structured data regarding patient characteristics, 'events' (symptoms, laboratory results), diagnoses (ICD10) and drug therapy were collected using a computer-supported data entry system and an interface for data retrieval from electronic patient records. ADR data were collected by 'event monitoring' to minimize possible bias by the drug monitor. The causality of each event was assessed in relation to disease(s) and drug therapy. RESULTS: The analysis included 4331 (100%) hospitalizations. The median observation period was 8 days. The median number of different drugs administered per patient and day was 6 and varied between 4 (Q1 ) and 9 (Q3 ) different drugs in 50% of all hospital days. In 41% of all hospitalizations at least one disease-unrelated event could be possibly attributed to drug therapy. Clinically relevant ADRs occurred in 11% of all hospitalizations. In 3.3% of all hospitalizations ADRs were the cause of hospital admission. The incidence of possibly ADR-related deaths was 1.4. Factors predisposing for clinically relevant ADRs were female gender and polypharmacy. ADR-related excess hospital stay accounted for 8. 6% of hospital days. CONCLUSIONS: These data demonstrate the feasibility of the developed 'event monitoring' system for quantitative analysis of ADRs in medical inpatients. With increasing numbers of recorded patients the pharmacoepidemiological database provides a valuable tool to study specific questions regarding drug efficacy and safety in hospitalized patients.  (+info)

Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. (5/263)

Among 105 patients given recombinant tissue plasminogen activator (rt-PA, alteplase) intravenously for acute stroke, 2 (1.9%) had lingual angioedema, which progressed to a fatal anaphylactoid reaction in 1. The authors review the 2 cases and possible mechanisms responsible. They warn that patients who are taking an angiotensin-converting-enzyme inhibitor may be at increased risk for angioedema with concomitant alteplase therapy.  (+info)

Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality. (6/263)

A patient with a lymphoproliferative disorder, angioedema, and an acquired deficiency of the inhibitor of the activated first component of complement was studied. The patient's complement profile revealed depletion of the first component of complement, which has not been seen in angioedema of the hereditary type. There was no evidence for C1-depleting activity in the patient's plasma. The majority of the patient's peripheral blood mononuclear cells resembled B cells in their memebrane receptor properties and in that they carried easily detectable immunoglobulin, predominantly IgM. However, these cells were unusual in that they phagocytosed both latex particles and C3-coated erythrocytes. Morphological study of the cells infiltrating the patient's lung revealed immature, atypical, and plasmacytoid lymphocytes and immunoblasts. Both the patient's peripheral blood mononuclear cells and a suspension of cells from the pulmonary infiltrate were capable of depleting the first component of complement and its inhibitor from homologous plasma. Normal ABO-compatible cells did not possess this property. The data suggested that the patient's abnormal lymphoid cells may have interacted with the complement system to produce a biochemical defect and a clinical syndrome closely resembling angioedema of the hereditary type.  (+info)

Laparoscopic splenectomy in a patient with acquired angioneurotic edema. (7/263)

BACKGROUND: We report the case of a 77-year-old female with acquired angioneurotic edema, C1 esterase inhibitor level = 4mg/dL, who was scheduled to undergo laparoscopic splenectomy. METHODS: In the operating room, we administered on call 500 units (UI) of C1 esterase inhibitor concentrate intravenously. Intraoperative hemodynamic instability and generalized blood oozing improved following the administration of aprotinin 250000 UI intravenous (IV) drip. CONCLUSION: We recommend the administration of an antifibrinolytic agent in addition to C1 esterase inhibitor concentrate in patients with acquired angioneurotic edema.  (+info)

The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes. (8/263)

Circulating immune complexes were identified in cryoproteins isolated from serial samples of serum from six patients with acute viral hepatitis with and without arthritic symptoms. Cryoprecipitates were analyzed for the presence of hepatitis-B surface antigen (HBsAg) and hepatitis-B surface antibody (anti-HBs) by hemagglutination inhibition and hemagglutination. Complement components were detected by counter electrophoresis, and immunoglobulins were detected by gel diffusion. HBsAg, IgG, and IgM were identified in cryoprecipitates from all hepatitis patients, but were higher in concentration in patients with arthritis. Only cryoprecipitates from hepatitis patients with arthritis contained IgA and complement components C3, C4, and C5 as well as IgG and IgM, which disappear with resolution of the arthritis. The subtypes of IgG in these cryoprecipitates were predominantly the complement-fixing IgG1 and IgG3, HBsAg and anti-HBs were concentrated several-fold in the cryoprecipitates when compared to the serum concentration. Sequential studies in two patients demonstrated that the initial appearance of anti-HBs in the cryoprotein complex was associated with the detection in the complex of IgM suggesting a primary immune response to HBsAg. The C3 activator fragment (C3A) of the properdin complex was found in fresh serum obtained from three hepatitis patients with arthritis and not in uncomplicated hepatitis. The cryoprecipitable immune complexes from patients with arthritis converted C3PA in fresh normal sera to C3A in vitro whereas cryoprotein isolated from patients with uncomplicated hepatitis had no such effect. Thus, the transient appearance of circulating complement-fixing immune complexes in patients with the arthritis of acute hepatitis is associated with activation of both classical and alternate complement pathways and suggests that they play an important role in the pathogenesis of these serum sickness-like extrahepatic symptoms.  (+info)

Angioedema is a medical condition characterized by rapid swelling of the skin, mucous membranes, and submucosal tissues. The swelling typically occurs in the face, lips, tongue, larynx, and extremities, and can also affect the gastrointestinal tract. Angioedema can be caused by a variety of factors, including allergic reactions, hereditary genetic mutations, and certain medications.

In medical terms, angioedema is defined as a self-limiting episode of localized edema in the deep dermis, subcutaneous tissue, or mucous membranes, characterized by well-circumscribed, nonpitting, nondependent swelling. The swelling can occur suddenly and may persist for up to 72 hours. In severe cases, angioedema can cause airway obstruction and be life-threatening if not treated promptly.

Angioedema can be classified into two main types: allergic or non-allergic. Allergic angioedema is caused by an immune response to an allergen, such as food, medication, or insect venom. Non-allergic angioedema can be further divided into several subtypes, including hereditary angioedema (HA), acquired angioedema (AAE), and drug-induced angioedema.

Hereditary angioedema is a rare genetic disorder caused by mutations in the C1 inhibitor gene, leading to uncontrolled activation of the complement system and increased production of bradykinin, a potent vasodilator. Acquired angioedema is similar to hereditary angioedema but occurs later in life and is associated with underlying medical conditions such as lymphoproliferative disorders or autoimmune diseases. Drug-induced angioedema can be caused by a variety of medications, including ACE inhibitors, angiotensin receptor blockers (ARBs), and nonsteroidal anti-inflammatory drugs (NSAIDs).

The diagnosis of angioedema is typically based on clinical presentation, medical history, and laboratory tests. Treatment depends on the underlying cause of the condition but may include antihistamines, corticosteroids, epinephrine, and medications that target the complement system or bradykinin pathway. In severe cases, hospitalization and intensive care may be necessary to manage airway obstruction and other complications.

Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of swelling in various parts of the body, including the face, lips, tongue, throat, hands, feet, and/or genitals. The swelling can also affect the gastrointestinal tract, causing abdominal pain, nausea, vomiting, and diarrhea.

HAE is caused by a deficiency or dysfunction of the C1 inhibitor protein, which is a part of the body's immune system that helps regulate inflammation and blood vessel dilation. As a result, people with HAE have uncontrolled activation of the complement system and increased levels of bradykinin, a potent vasodilator that causes the characteristic swelling.

There are three types of HAE: type I, type II, and type III. Type I and type II are caused by mutations in the gene that codes for the C1 inhibitor protein, resulting in low levels or dysfunctional C1 inhibitor protein. Type III is caused by a mutation in the coagulation factor XII gene, leading to overactivation of the contact system and increased bradykinin production.

HAE is an inherited disorder, typically passed down from parent to child in an autosomal dominant pattern. This means that a person has a 50% chance of inheriting the mutated gene from an affected parent and developing HAE. However, up to 25% of cases may occur spontaneously due to new mutations in the gene.

Treatment for HAE includes medications to prevent or reduce the severity and frequency of attacks, such as C1 inhibitor replacement therapy, attenuated androgens, and monoclonal antibodies against kallikrein. In addition, acute attacks can be treated with on-demand therapies, such as plasma-derived C1 inhibitor, icatibant, and ecallantide.

Hereditary angioedema (HAE) is a rare genetic disorder that affects the body's immune system and causes recurring episodes of swelling (angioedema). The two most common types of HAE are Type I and Type II, which are caused by mutations in the SERPING1 gene.

Type I HAE: This is the most common form of HAE, accounting for about 85% of cases. In Type I HAE, there is a deficiency of C1 inhibitor (C1-INH), a protein that helps regulate the immune system and prevent inflammation. As a result, levels of bradykinin, a peptide that causes blood vessels to dilate and leads to swelling, are increased. This can cause episodes of swelling in various parts of the body, including the face, hands, feet, and airways.

Type II HAE: This form of HAE is less common than Type I, accounting for about 15% of cases. In Type II HAE, there are normal or even elevated levels of C1-INH in the blood, but the protein is dysfunctional and cannot properly regulate the immune system. This also leads to increased levels of bradykinin and episodes of angioedema.

Both types of HAE can be serious and potentially life-threatening if swelling occurs in the airways and obstructs breathing. Treatment typically involves medications that help control the production of bradykinin or block its effects, as well as measures to prevent and manage symptoms during an acute attack.

The Complement C1 Inhibitor protein, also known as C1-INH, is a protein involved in the regulation of the complement system and the contact system, which are parts of the immune system. The complement system helps to eliminate pathogens (e.g., bacteria, viruses) from the body, while the contact system helps to regulate blood coagulation and inflammation.

C1-INH works by inhibiting the activation of C1, an enzyme complex that is the first component of the classical complement pathway. By inhibiting C1, C1-INH prevents the activation of downstream components of the complement system, thereby helping to regulate the immune response and prevent excessive inflammation.

Deficiencies or dysfunction in the C1-INH protein can lead to a group of genetic disorders known as C1 inhibitor deficiency disorders, which include hereditary angioedema (HAE) and acquired angioedema (AAE). These conditions are characterized by recurrent episodes of swelling in various parts of the body, such as the face, hands, feet, and airway, which can be painful and potentially life-threatening if they affect the airway.

Complement C1 Inactivator proteins are a part of the complement system, which is a group of proteins in the blood that play a crucial role in the body's immune defense system. Specifically, Complement C1 Inactivator proteins are responsible for regulating the activation of the first component of the complement system, C1.

The complement system is activated in response to the presence of foreign substances such as bacteria or viruses in the body. The activation of C1 leads to a cascade of reactions that result in the destruction of the foreign substance. However, if this process is not properly regulated, it can lead to damage to the body's own cells and tissues.

Complement C1 Inactivator proteins help to prevent this by regulating the activation of C1. They do this by binding to and inhibiting the activity of C1, preventing it from initiating the complement cascade. A deficiency in Complement C1 Inactivator proteins can lead to a condition called hereditary angioedema, which is characterized by recurrent episodes of swelling in various parts of the body.

Urticaria, also known as hives, is an allergic reaction that appears on the skin. It is characterized by the rapid appearance of swollen, pale red bumps or plaques (wheals) on the skin, which are often accompanied by itching, stinging, or burning sensations. These wheals can vary in size and shape, and they may change location and appear in different places over a period of hours or days. Urticaria is usually caused by an allergic reaction to food, medication, or other substances, but it can also be triggered by physical factors such as heat, cold, pressure, or exercise. The condition is generally harmless, but severe cases of urticaria may indicate a more serious underlying medical issue and should be evaluated by a healthcare professional.

Hereditary Angioedema (HAE) Type III is a rare genetic disorder characterized by recurrent episodes of severe swelling (angioedema) that can affect various parts of the body, including the hands, feet, limbs, face, and airway. Unlike HAE Types I and II, which are caused by deficiency or dysfunction of the C1 inhibitor protein, HAE Type III is associated with normal C1 inhibitor levels but increased activation of the contact system, leading to bradykinin-mediated vasodilation and increased vascular permeability.

HAE Type III primarily affects women and is often triggered by estrogen fluctuations, such as those occurring during pregnancy, menstruation, or the use of oral contraceptives. The symptoms of HAE Type III can be similar to those of HAE Types I and II but may also include abdominal pain, nausea, vomiting, and diarrhea.

It is important to note that the medical community has debated whether HAE Type III is a distinct clinical entity or a variant of other forms of HAE. Some experts consider it to be a form of acquired angioedema (AAE) rather than a hereditary disorder. Regardless, prompt diagnosis and appropriate management are essential for preventing potentially life-threatening complications, such as airway obstruction.

Danazol is a synthetic, orally active androgenic steroid with antigonadotropic properties. It is used primarily in the treatment of endometriosis, fibrocystic breast disease, and hereditary angioedema. Danazol works by suppressing the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland, which in turn inhibits the growth of ovarian tissue and reduces the production of estrogen and progesterone. This leads to a decrease in the symptoms associated with endometriosis and fibrocystic breast disease. In the case of hereditary angioedema, danazol helps prevent attacks by increasing the levels of a protein called C1 esterase inhibitor, which is necessary for regulating the immune system and preventing inflammation.

The common side effects of danazol include weight gain, acne, oily skin, increased hair growth, changes in menstrual cycle, decreased breast size, deepening of the voice, and emotional lability. Rare but serious side effects may include liver damage, blood clots, and adrenal gland problems. Danazol is contraindicated in pregnancy due to its potential virilizing effects on the fetus. It should be used with caution in individuals with a history of liver disease, heart disease, or seizure disorders.

The medical definition of danazol can be summarized as follows:

Danazol (dan-a-zole)

A synthetic androgenic steroid with antigonadotropic properties, used primarily in the treatment of endometriosis, fibrocystic breast disease, and hereditary angioedema. Danazol suppresses the release of FSH and LH from the pituitary gland, inhibiting ovarian tissue growth and reducing estrogen and progesterone production. In hereditary angioedema, danazol increases C1 esterase inhibitor levels to prevent attacks. Common side effects include weight gain, acne, increased hair growth, menstrual changes, decreased breast size, deepened voice, and emotional lability. Rare but serious side effects may involve liver damage, blood clots, or adrenal gland problems. Danazol is contraindicated in pregnancy due to potential virilizing effects on the fetus and should be used with caution in individuals with a history of liver disease, heart disease, or seizure disorders.

Stanozolol is a synthetic anabolic-androgenic steroid (AAS) derivative of dihydrotestosterone (DHT). It is commonly used in medicine for the treatment of hereditary angioedema and was formerly used to promote muscle growth in weakened or catabolic patients. Stanozolol has a high anabolic and moderate androgenic activity, with reduced estrogenic properties compared to testosterone. Its chemical formula is (17α-methyl-5α-androstano[2,3-c]pyrazol-17β-ol). It is important to note that the use of Stanozolol for performance enhancement is considered illegal and subject to severe penalties in many countries, including disqualification from sports events and criminal charges.

Drug hypersensitivity is an abnormal immune response to a medication or its metabolites. It is a type of adverse drug reaction that occurs in susceptible individuals, characterized by the activation of the immune system leading to inflammation and tissue damage. This reaction can range from mild symptoms such as skin rashes, hives, and itching to more severe reactions like anaphylaxis, which can be life-threatening.

Drug hypersensitivity reactions can be classified into two main types: immediate (or IgE-mediated) and delayed (or non-IgE-mediated). Immediate reactions occur within minutes to a few hours after taking the medication and are mediated by the release of histamine and other inflammatory mediators from mast cells and basophils. Delayed reactions, on the other hand, can take several days to develop and are caused by T-cell activation and subsequent cytokine release.

Common drugs that can cause hypersensitivity reactions include antibiotics (such as penicillins and sulfonamides), nonsteroidal anti-inflammatory drugs (NSAIDs), monoclonal antibodies, and chemotherapeutic agents. It is important to note that previous exposure to a medication does not always guarantee the development of hypersensitivity reactions, as they can also occur after the first administration in some cases.

The diagnosis of drug hypersensitivity involves a thorough medical history, physical examination, and sometimes skin or laboratory tests. Treatment typically includes avoiding the offending medication and managing symptoms with antihistamines, corticosteroids, or other medications as needed. In severe cases, emergency medical care may be required to treat anaphylaxis or other life-threatening reactions.

Complement inactivating agents are substances or drugs that inhibit the complement system, which is a part of the immune system responsible for the recognition and elimination of foreign substances and microorganisms. The complement system consists of a group of proteins that work together to help eliminate pathogens from the body.

Complement inactivating agents are used in medical settings to prevent or treat various conditions associated with excessive or unwanted activation of the complement system, such as inflammation, autoimmune diseases, and transplant rejection. These agents can inhibit different components of the complement pathway, including C1 esterase inhibitors, C3 convertase inhibitors, and C5a receptor antagonists.

Examples of complement inactivating agents include eculizumab, ravulizumab, and Alexion's Ultomiris, which are monoclonal antibodies that target C5, a protein involved in the final steps of the complement pathway. These drugs have been approved for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and other complement-mediated diseases.

Other complement inactivating agents include C1 esterase inhibitors, such as Berinert and Ruconest, which are used to treat hereditary angioedema (HAE). These drugs work by inhibiting the activation of the classical pathway of the complement system, thereby preventing the release of inflammatory mediators that can cause swelling and pain.

Overall, complement inactivating agents play an important role in the treatment of various complement-mediated diseases, helping to reduce inflammation, prevent tissue damage, and improve patient outcomes.

Tongue diseases refer to various medical conditions that affect the structure, function, or appearance of the tongue. These conditions can be categorized into several types, including:

1. Infections: Bacterial, viral, or fungal infections can cause tongue inflammation (glossitis), pain, and ulcers. Common causes include streptococcus, herpes simplex, and candida albicans.
2. Traumatic injuries: These can result from accidental bites, burns, or irritation caused by sharp teeth, dental appliances, or habitual habits like tongue thrusting or chewing.
3. Neoplasms: Both benign and malignant growths can occur on the tongue, such as papillomas, fibromas, and squamous cell carcinoma.
4. Congenital disorders: Some individuals may be born with abnormalities of the tongue, like ankyloglossia (tongue-tie) or macroglossia (enlarged tongue).
5. Neurological conditions: Certain neurological disorders can affect tongue movement and sensation, such as Bell's palsy, stroke, or multiple sclerosis.
6. Systemic diseases: Various systemic conditions can have symptoms that manifest on the tongue, like diabetes mellitus (which can cause dryness and furring), iron deficiency anemia (which may lead to atrophic glossitis), or Sjögren's syndrome (which can result in xerostomia).
7. Idiopathic: In some cases, the cause of tongue symptoms remains unknown, leading to a diagnosis of idiopathic glossitis or burning mouth syndrome.

Proper diagnosis and treatment of tongue diseases require a thorough examination by a healthcare professional, often involving a dental or medical specialist such as an oral pathologist, otolaryngologist, or dermatologist.

Skin tests are medical diagnostic procedures that involve the application of a small amount of a substance to the skin, usually through a scratch, prick, or injection, to determine if the body has an allergic reaction to it. The most common type of skin test is the patch test, which involves applying a patch containing a small amount of the suspected allergen to the skin and observing the area for signs of a reaction, such as redness, swelling, or itching, over a period of several days. Another type of skin test is the intradermal test, in which a small amount of the substance is injected just beneath the surface of the skin. Skin tests are used to help diagnose allergies, including those to pollen, mold, pets, and foods, as well as to identify sensitivities to medications, chemicals, and other substances.

Anaphylaxis is a severe, life-threatening systemic allergic reaction that occurs suddenly after exposure to an allergen (a substance that triggers an allergic reaction) to which the person has previously been sensitized. The symptoms of anaphylaxis include rapid onset of symptoms such as itching, hives, swelling of the throat and tongue, difficulty breathing, wheezing, cough, chest tightness, rapid heartbeat, hypotension (low blood pressure), shock, and in severe cases, loss of consciousness and death. Anaphylaxis is a medical emergency that requires immediate treatment with epinephrine (adrenaline) and other supportive measures to stabilize the patient's condition.

Angiotensin-Converting Enzyme (ACE) inhibitors are a class of medications that are commonly used to treat various cardiovascular conditions, such as hypertension (high blood pressure), heart failure, and diabetic nephropathy (kidney damage in people with diabetes).

ACE inhibitors work by blocking the action of angiotensin-converting enzyme, an enzyme that converts the hormone angiotensin I to angiotensin II. Angiotensin II is a potent vasoconstrictor, meaning it narrows blood vessels and increases blood pressure. By inhibiting the conversion of angiotensin I to angiotensin II, ACE inhibitors cause blood vessels to relax and widen, which lowers blood pressure and reduces the workload on the heart.

Some examples of ACE inhibitors include captopril, enalapril, lisinopril, ramipril, and fosinopril. These medications are generally well-tolerated, but they can cause side effects such as cough, dizziness, headache, and elevated potassium levels in the blood. It is important for patients to follow their healthcare provider's instructions carefully when taking ACE inhibitors and to report any unusual symptoms or side effects promptly.

Bradykinin is a naturally occurring peptide in the human body, consisting of nine amino acids. It is a potent vasodilator and increases the permeability of blood vessels, causing a local inflammatory response. Bradykinin is formed from the breakdown of certain proteins, such as kininogen, by enzymes called kininases or proteases, including kallikrein. It plays a role in several physiological processes, including pain transmission, blood pressure regulation, and the immune response. In some pathological conditions, such as hereditary angioedema, bradykinin levels can increase excessively, leading to symptoms like swelling, redness, and pain.

Complement C4 is a protein that plays a crucial role in the complement system, which is a part of the immune system that helps to clear pathogens and damaged cells from the body. Complement C4 is involved in the early stages of the complement activation cascade, where it helps to identify and tag foreign or abnormal cells for destruction by other components of the immune system.

Specifically, Complement C4 can be cleaved into two smaller proteins, C4a and C4b, during the complement activation process. C4b then binds to the surface of the target cell and helps to initiate the formation of the membrane attack complex (MAC), which creates a pore in the cell membrane and leads to lysis or destruction of the target cell.

Deficiencies or mutations in the Complement C4 gene can lead to various immune disorders, including certain forms of autoimmune diseases and susceptibility to certain infections.

Ant venoms are toxic secretions produced by various species of ants as a defense mechanism against predators and to incapacitate their prey. The composition of ant venoms varies among different species, but they typically contain a mixture of alkaloids, peptides, and proteins that can cause a range of symptoms in humans, from mild irritation and pain to severe allergic reactions.

The venom of some ant species, such as the fire ants (Solenopsis spp.), contains alkaloids that can cause painful pustules and itching, while the venom of other species, like the bulldog ants (Myrmecia spp.), contains proteins that can induce severe allergic reactions and even anaphylactic shock in sensitive individuals.

Understanding the composition and effects of ant venoms is important for developing effective treatments for ant stings and for studying their potential therapeutic applications, such as using ant venom components in pain management or as leads for new drug development.

Stomatognathic diseases are a group of disorders that affect the stomatognathic system, which includes the teeth, periodontal tissues, temporomandibular joints, muscles of mastication, and associated structures. These diseases can manifest as various symptoms such as pain, difficulty in chewing or swallowing, limited mouth opening, and abnormal jaw movements.

Some examples of stomatognathic diseases include temporomandibular disorders (TMD), oral mucosal diseases, dental caries, periodontal disease, oral cancer, and sleep-related breathing disorders. The diagnosis and management of these conditions often require a multidisciplinary approach involving dentists, oral surgeons, orthodontists, physicians, and other healthcare professionals.

... can be due to antibody formation against C1INH; this is an autoimmune disorder. This acquired angioedema is ... In acquired angioedema, HAE types I and II, and nonhistaminergic angioedema, antifibrinolytics such as tranexamic acid or ε- ... Angioedema is classified as either hereditary or acquired. Acquired angioedema (AAE) can be immunologic, nonimmunologic, or ... Drug-induced angioedema Gleich's syndrome (unexplained angioedema with high eosinophil counts) Ruconest (C1-inhibitor) ...
... due to Factor XII dysfunction is the most common subtype of type III angioedema. A second molecular ... Hereditary angioedema type 3 (hereditary angioedema with normal C1 inhibitor levels) is associated with mutations in genes for ... With regards to the mutations in the SERPING1 gene that is seen in hereditary angioedema types 1 and 2 (hereditary angioedema ... Urticaria is usually not seen in hereditary angioedema, as compared to other causes of angioedema such as histamine induced ...
... is a form of physical urticaria that may be an inherited autosomal dominant trait, or may be acquired ... Urticaria and angioedema, All stub articles, Cutaneous condition stubs). ...
120 The angioedema appears to be dose dependent as it may resolve with decreased dose.: 120 Angioedema presents itself as an ... Drug-induced angioedema is a known complication of the use of angiotensin-converting enzyme (ACE) inhibitors, angiotensin II ... Some common locations of angioedema are the face, particularly the lips and around the eyes, hands and feet, and genitalia. A ... Angioedema Skin lesion James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical ...
Angioedema is also a common response to oral, vaginal, or rectal contact. Symptoms of more severe hypersensitivity include both ... local and generalized hives; feelings of faintness or impending doom; angioedema; nausea and vomiting; abdominal cramps; ...
Angioedema may be associated with hereditary or acquired angioedema where it may be mast cell independent and result from kinin ... Recurrent idiopathic anaphylaxis presents with allergic signs and symptoms-hives and angioedema which is a distinguishing ... generation) a. Anaphylaxis b. Angioedema c. Urticaria d. Mast cell activation syndrome (MCAS)... ...
Church MK (2021). "Antihistamines". Urticaria and Angioedema. Springer International Publishing. pp. 153-165. doi:10.1007/978-3 ...
Angioedema is similar to hives, but in angioedema, the swelling occurs in a lower layer of the dermis than in hives, as well as ... Hives and angioedema sometimes occur together in response to an allergen, and is a concern in severe cases, as angioedema of ... "angioedema" at Dorland's Medical Dictionary "Hives (Urticaria and Angioedema)". 2006-03-01. Archived from the original on 2007- ... This very rare form of angioedema develops in response to contact with vibration. In vibratory angioedema, symptoms develop ...
Grattan, Clive; Black, A. K. (2003). "Urticaria and angioedema". In Bolognia, Jean; Jorrizo, Joseph L.; Rapini, Ronald P. (eds ... "Natural course of physical and chronic urticaria and angioedema in 220 patients". Journal of the American Academy of ...
Church, Martin K. (2021). "Antihistamines". Urticaria and Angioedema. Springer International Publishing. pp. 153-165. doi: ...
It is decreased during attacks of hereditary angioedema (but those with the disease have a normal value in between attacks). ... Michael M Frank, MD (2018-08-30). "Hereditary Angioedema Workup". Medscape. v t e (All articles with unsourced statements, ...
Spickett G (2014). "Urticaria and angioedema". J R Coll Physicians Edinb. 44 (1): 50-4. doi:10.4997/JRCPE.2014.112. PMID ... angioedema, ulcerative colitis, pericarditis, temporal arteritis and Crohn's disease, Bell's palsy, multiple sclerosis, cluster ...
Kanani, Amin; Schellenberg, Robert; Warrington, Richard (2011-11-10). "Urticaria and angioedema". Allergy, Asthma & Clinical ...
335 Branco-Ferreira M, Pedro E, Barbosa MA, Carlos AG (1998). "Ascites in hereditary angioedema". Allergy. 53 (5): 543-5. doi: ... Serositis Nephrotic syndrome Hereditary angioedema Other rare causes[citation needed] Meigs syndrome Vasculitis Hypothyroidism ...
At that time, the drug had not been discontinued and was considered a treatment for hereditary angioedema. In March 2009, ... It is also being studied to treat hereditary angioedema, osteoporosis, and skeletal muscle injury. Stanozolol is used for ... Sloane DE, Lee CW, Sheffer AL (September 2007). "Hereditary angioedema: Safety of long-term stanozolol therapy". The Journal of ... ISBN 978-1-118-68590-7. Delves PJ (March 2014). "Hereditary and Acquired Angioedema". Merck Manual. Morton IK, Hall JM (6 ...
Contraindications are hypersensitivity against ACE inhibitors, especially if it has resulted in angioedema; idiopathic or ... hereditary angioedema; kidney failure; the second and third trimesters in pregnancy; and combination with the drug aliskiren in ...
In severe cases, the elevation of bradykinin may result in angioedema, a medical emergency. People of African descent have up ... Overactivation of bradykinin is thought to play a role in a rare disease called hereditary angioedema. Low levels of bradykinin ... Guyer AC, Banerji A. "ACE inhibitor-induced angioedema". UpToDate. Retrieved 2018-06-03. Bas M, Adams V, Suvorava T, Niehues T ... increased risk of ACE inhibitor induced angioedema due to hereditary predisposing risk factors such as hereditary angioedema. ...
CDKL5 Angioedema, hereditary, type III; 610618; F12 Angioedema, hereditary, types I and II; 106100; C1NH Angiopathy, hereditary ...
Cahill K (2018). "Urticaria, Angioedema, and Allergic Rhinitis." 'Harrison's Principles of Internal Medicine (20th ed.). NY: ...
... is a rare disease in which the body swells up episodically (angioedema), associated with raised antibodies of ... Gleich GJ, Schroeter AL, Marcoux JP, Sachs MI, O'Connell EJ, Kohler PF (1984). "Episodic angioedema associated with ... Articles with short description, Short description matches Wikidata, Urticaria and angioedema, Immune system disorders, ...
It often occurs as a harbinger of attacks in hereditary angioedema. In this case it may occur several hours or up to a day ... An association with bradykinin has been proposed in the case of hereditary angioedema. The rings are barely raised and are non- ... ISBN 978-1-4160-2999-1. Starr JC, Brasher GW, Rao A, Posey D (October 2004). "Erythema marginatum and hereditary angioedema". ... The condition is also seen as a precursor to or accompany an attack of angioedema, and is seen in conditions like allergic drug ...
Davis AE (January 2008). "Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema". ... Bernstein JA (January 2008). "Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging ... Davis AE (January 2005). "The pathophysiology of hereditary angioedema". Clinical Immunology. 114 (1): 3-9. doi:10.1016/j.clim. ... Li HH (7 September 2016). "Self-administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: ...
Angioedema, which can occur alone or with urticaria, is characterized by a well-defined, edematous swelling that involves ... Muller BA (2004). "Urticaria and angioedema: a practical approach". Am Fam Physician. 69 (5): 1123-8. PMID 15023012. Carlson JA ... Episodic angioedema with eosinophilia (Gleich's syndrome) Exercise urticaria (exercise-induced urticaria) Galvanic urticaria ... Chemotherapy-induced hyperpigmentation Drug-induced acne Drug-induced angioedema Drug-related gingival hyperplasia Drug-induced ...
Muller BA (March 2004). "Urticaria and angioedema: a practical approach". American Family Physician. 69 (5): 1123-28. PMID ... reaction characteristic of hives and angioedema. With insect stings, a large local reaction may occur in the form of an area of ...
... (trade name Kalbitor) is a drug used for the treatment of hereditary angioedema (HAE) and in the prevention of ... Ecallantide does not appear to be efficacious for the treatment of angioedema due to ACE inhibitors. The most common adverse ... On November 27, 2009, ecallantide was approved by the FDA for the treatment of acute attacks of hereditary angioedema for ... Lehmann A (August 2008). "Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the ...
Jerini focused on treating hereditary angioedema. In 2008, in reaction to new taxation measures announced by the UK government ... Endocrine and Hereditary Angioedema; a growing franchise in Oncology; and an emerging, innovative pipeline in Ophthalmics. The ... the company's rare disease catalogue with Dyax's portfolio of plasma kallikrein inhibitors against hereditary angioedema (led ...
Some (0.7%) develop angioedema due to increased bradykinin levels. A genetic predisposition may exist. A severe rare allergic ... doi:10.1016/b978-0-323-47871-7.00078-2. ISBN 978-0-323-47871-7. Angioedema (0.7%) can also occur via pathobiology that remains ... This mechanism can explain the two most common side effects seen with ACE Inhibitors: angioedema and cough. Frequently ... The ACE inhibitors are contraindicated in people with: Pregnancy or breastfeeding Previous angioedema associated with ACE ...
It is also used in the treatment of idiopathic short stature, anemia, hereditary angioedema, alcoholic hepatitis, and ... Bork K (August 2012). "Current management options for hereditary angioedema". Current Allergy and Asthma Reports. 12 (4): 273- ...
Hypersensitivity reactions are rare and include angioedema. The substance is metabolized by the liver enzyme CYP3A4. ...
It is also used for hereditary angioedema. It is taken either orally or by injection into a vein. Tranexamic acid is a ...
Angioedema can be due to antibody formation against C1INH; this is an autoimmune disorder. This acquired angioedema is ... In acquired angioedema, HAE types I and II, and nonhistaminergic angioedema, antifibrinolytics such as tranexamic acid or ε- ... Angioedema is classified as either hereditary or acquired. Acquired angioedema (AAE) can be immunologic, nonimmunologic, or ... Drug-induced angioedema Gleichs syndrome (unexplained angioedema with high eosinophil counts) Ruconest (C1-inhibitor) ...
Angioedema is swelling that is similar to hives, but the swelling is under the skin instead of on the surface. ... Angioedema is swelling that is similar to hives, but the swelling is under the skin instead of on the surface. ... Angioedema is swelling that is similar to hives, but the swelling is under the skin instead of on the surface. ... Angioedema that does not affect the breathing may be uncomfortable. It is usually harmless and goes away in a few days. ...
Angioedema, first described in 1586, is usually defined by pronounced swelling of the deep dermis, subcutaneous or submucosal ... Pseudoallergic angioedema. "Pseudoallergic" angioedema (PAE) is not mediated by IgE; that is, the angioedema is caused by a ... Histamine- and bradykinin-mediated angioedema. For histamine-mediated angioedema (histaminergic angioedema), mast cells and ... inhibitor-induced angioedema, and certain idiopathic angioedemas are examples of bradykinin-mediated angioedema; bradykinin ...
In Practice asks are we already decreasing Hereditary Angioedema mortality? ... Deaths from asphyxia in patients with Hereditary Angioedema (HAE) have been reported since the first descriptions of the ...
... and angioedema, including their causes, diagnosis, treatment, and management. ... Hives, Urticaria, and Angioedema Medically Reviewed by Jabeen Begum, MD on April 17, 2023 ... Hereditary angioedema: Painful swelling under the skin. It runs in families.. Diagnosis. Your doctor will ask you many ... Angioedema is different. The swelling happens under the skin, not on the surface. Its marked by deep swelling around the eyes ...
There are several treatments available for hereditary angioedema that can both prevent attacks and treat them once they begin. ... Angioedema is severe swelling beneath the skin. Sometimes the swelling is accompanied by hives. Learn about angioedema symptoms ... Your FAQs, Answered: What Is a Hereditary Angioedema Attack?. What is a hereditary angioedema (HAE) attack, and how long does ... More in Taking Charge of Hereditary Angioedema. *. Hereditary Angioedema Doctor: Building Your Care Team ...
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. ...
Angioedema. Posted on Thursday, May 15th, 2008 Ever have one of those days where everything sucks?. ...
Patients with NSAID-induced urticaria and/or angioedema (NIUA) do not have spontaneous urticaria and/or angioedema, but only ... NSAID-induced urticaria/angioedema (NIUA), two clinical phenotypes (NSAID induced isolated periorbital angioedema and NSAID ... 3.3 Isolated periorbital angioedema (iPA), or the infanto-juvenile form of NH. This type of reaction usually affects children ... Clinical Phenotypes in NSAID-Induced Urticaria/Angioedema. Written By. Joaquin Quiralte, María del Robledo Ávila, Stefan ...
US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema ... Hereditary angioedema (HAE) is a rare genetic disease defined by recurrent attacks of edema, causing a substantial burden for ... Hereditary angioedema: the economics of treatment of an orphan disease. Front Med (Lausanne). 2018;5:22. doi: 10.3389/fmed. ... Prevention of hereditary angioedema attacks with a subcutaneous C1 inhibitor. N Engl J Med. 2017; 376:1131-1140. doi: 10.1056/ ...
Video / Health Topics A-Z / Ask the Experts / Ask the Experts: Hereditary Angioedema Risks and Causes ... Ask the Experts: Hereditary Angioedema Risks and Causes (1:39) Hereditary angioedima (HAE) is a rare condition that causes ...
Hereditary angioedema (HAE) is a rare but important disease caused by a genetic deficiency or impaired function of the C1- ... Hereditary angioedema (HAE) - epidemiology, genetics and pathophysiologys profile in Lund University Research portal ...
Patients in Wales are to get access to ViroPharmas hereditary angioedema (HAE) drug Cinryze on the National Health Service ... Patients in Wales are to get access to ViroPharmas hereditary angioedema (HAE) drug Cinryze on the National Health Service ... The European Commission approved Cinryze for the prevention and treatment of angioedema attacks in adults and adolescents with ... NHS patients in Wales to get access to angioedema drug. 26th March 2013. ...
Recent advances in the treatment of hereditary angioedema, particularly in the last decade has been promising. This paper ... PDF: New Treatments for Hereditary Angioedema. $1.99. PDF Download: Recent advances in the treatment of hereditary angioedema, ...
Angioedema is red painful swelling in the subcutaneous tissue, triggered by an allergic reaction or medication. It most ... For more information, see Hereditary angioedema. What is the outcome for angioedema?. The prognosis of angioedema is dependent ... What is the treatment for angioedema?. Treatment is dependent on the subtype of angioedema. Angioedema is usually treated in ... Inducible angioedema. *A form of chronic inducible urticaria. *Rarely vibration (vibratory angioedema) and cold stimuli can ...
Hereditary angioedema (HAE) is an autosomal dominant, potentially life-threatening condition, manifesting as recurrent and self ... Hereditary angioedema: epidemiology, management, and role of icatibant Aasia Ghazi, J Andrew GrantUniversity of Texas Medical ... Abstract: Hereditary angioedema (HAE) is an autosomal dominant, potentially life-threatening condition, manifesting as ...
... to prevent attacks of hereditary angioedema (HAE) in patients aged 12 years and older. ... Close more info about FDA Approves Orladeyo to Prevent Hereditary Angioedema Attacks ... Close more info about FDA Approves Orladeyo to Prevent Hereditary Angioedema Attacks ... which assessed the efficacy and safety of Orladeyo in preventing angioedema attacks in patients aged 12 years and older with ...
Hereditary angioedema is a rare disease characterized by episodes of the accumulation of fluids outside of the blood vessels ... The earlier, higher estimates of the number of angioedema attacks raised the price range under which the therapies would be ... An analysis using claims data for three therapies to treat patients with hereditary angioedema attacks has found that larger ... In this updated study, de-identified claims data suggest that patients using these three therapies to prevent angioedema had ...
Comorbidities in hereditary angioedema-A population-based cohort study. *Mark. Sundler Björkman, Linda LU ; Persson, Barbro ; ... Background: In hereditary angioedema (HAE), low levels (type 1) or defect in function (type 2) of the serine-protease inhibitor ... Background: In hereditary angioedema (HAE), low levels (type 1) or defect in function (type 2) of the serine-protease inhibitor ... Hereditary angioedema (HAE) - epidemiology, genetics and pathophysiology (research group). * Division of Microbiology, ...
Hereditary angioedema; pregnancy; therapy; icatibant; recombinant C1 inhibitor Popis. PurposeHereditary angioedema (HAE) is a ... Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy. Autoři. HAKL Roman ... Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy ...
A Study to Evaluate the Safety and Effectiveness of Lanadelumab to Prevent Acute Attacks of Non-histaminergic Angioedema. ... Diagnosed with non-histaminergic normal C1-INH angioedema at the time of enrollment into the antecedent Study SHP643-303. ... administration of lanadelumab in adults with non-histaminergic angioedema with normal C1-inhibitor who completed study SHP643- ...
Angioedema following the intravenous administration of metoprolol. Chest 1994 Dec;106;1922-3 1994 Dec ...
Angioedema of the small bowel caused by lisinopril. BMJ Case Rep 2018. doi:10.1136/bcr-2018-225396 ...
We are dedicated to provide support and information on Hereditary Angioedema (HAE) to both patients and physicians, including ... The US Hereditary Angioedema Association (HAEA) is a 501(c)(3) non-profit organization.. © 2023 US Hereditary Angioedema ... The US Hereditary Angioedema Association. 10560 Main Street, Suite PS40. Fairfax City, VA 22030 ...
... gene therapy for the treatment of hereditary angioedema (HAE), a life-threatening rare disorder that causes recurring swelling ... and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo HSC Gene Therapy for Hereditary Angioedema. ... and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo HSC Gene Therapy for Hereditary Angioedema. ... and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo HSC Gene Therapy for Hereditary Angioedema ...
Genetic determination of bradykinin-mediated angioedema severity in patients with hereditary angioedema ... Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon Activation. Authors. HUJOVÁ Pavla SOUČEK ... Hereditary angioedema; SERPING1; pre-mRNA splicing; pseudoexon activation; donor splice site Description. Purpose Hereditary ... angioedema (HAE) is a rare autosomal dominant life-threatening disease characterized by low levels of C1 inhibitor (type I HAE ...
A listing of 0 Hereditary Angioedema (HAE) clinical trials in New Jersey actively recruiting volunteers for paid trials and ... Hereditary Angioedema (HAE) Paid Clinical Trials in New Jersey A listing of 0 Hereditary Angioedema (HAE) clinical trials in ...
Prevalence of Angioedema in Black Americans. ACE inhibitor-related Angioedema is one of the conditions which is common among ... The Manifestation of Angioedema. The manifestation of the angioedema condition affects the patient in many ways. More ... Essay on Angioedema Due to ACE Inhibitors: Increased Risk in People of Color. Published: 2021/11/04 Number of words: 1637 ... Angioedema has been a well-known side effect of the treatment of ACE inhibitors for patients with chronic heart failure and ...
Our research focuses on the co-creation of value in healthcare with reference to a case of hereditary angioedema with C1 ... From: Value co-creation in healthcare: evidence from innovative therapeutic alternatives for hereditary angioedema ...
  • Up to 20% of people will develop hives (urticaria) at some time in their life and around one in three of these will have angioedema as well. (allergy.org.au)
  • Having angioedema on its own (without hives) is much less common. (allergy.org.au)
  • Angioedema plus hives (urticaria): the hives itch and the angioedema is itchy, hot or painful. (allergy.org.au)
  • Allergy to foods or drugs usually causes hives (urticaria), or itching as well as angioedema at the same time. (allergy.org.au)
  • Food allergy reactions are sometimes severe, dramatic and often associated with symptoms like trouble breathing, a drop in blood pressure, stomach upset and itchy hives (urticaria), as well as angioedema. (allergy.org.au)
  • Angioedema is swelling that is similar to hives , but the swelling is under the skin instead of on the surface. (medlineplus.gov)
  • It is possible to have angioedema without hives. (medlineplus.gov)
  • Hives and angioedema may also occur after infections or with other illnesses (including autoimmune disorders such as lupus, and leukemia and lymphoma). (medlineplus.gov)
  • Allergic angioedema is skin reaction commonly associated with urticara (hives). (aaaai.org)
  • Angioedema can happen along with hives . (aafa.org)
  • Basically angioedema is swelling that occurs under the skin, rather than on the surface like hives. (ihealthdirectory.com)
  • The symptoms during angioedema are very similar to hives, but deeper, below the surface. (ihealthdirectory.com)
  • Unlike angioedema caused by an allergic reaction, hereditary angioedema and acquired angioedema do not cause hives or itching. (merckmanuals.com)
  • Both hives and angioedema involve swelling, but in angioedema, the swelling is deeper (under the skin) than it is with hives, and it may not itch. (msdmanuals.com)
  • Angioedema without hives is sometimes caused by ACE inhibitors, which are used to treat high blood pressure and heart failure. (msdmanuals.com)
  • Hives are not a part of hereditary angioedema , but can occur concurrently. (pedemmorsels.com)
  • But when I got the book I was shocked to see that tms might be the cause of my chronic hives & angioedema, which have plagued me for a decade. (tmswiki.org)
  • Angioedema alone: skin-coloured swellings, not itchy or burning, often unresponsive to antihistamines. (allergy.org.au)
  • Histamine-related angioedema can be treated with antihistamines, corticosteroids, and epinephrine. (wikipedia.org)
  • Except for ACEI-AAE (or AIIA), C1-INH-AAE, and different types of HAE, a significant proportion of angioedema can be adequately controlled with daily doses of nonsedating antihistamines. (medscape.com)
  • Although the pathophysiology of ACEI-induced angioedema is attributable to elevated serum bradykinin, standard management typically includes corticosteroids and antihistamines. (nih.gov)
  • With the milder forms of angioedema, you can usually treat the symptoms yourself at home using over-the-counter antihistamines and topical steroidal creams such as hydrocortisone. (ihealthdirectory.com)
  • Background: The X‐ACT study aimed to examine the effect of omalizumab treatment on quality of life (QoL) in chronic spontaneous urticaria (CSU) patients with angioedema refractory to high doses of H1‐antihistamines. (fu-berlin.de)
  • Specific emphasis is placed on the importance of the history of present illness, the role of laboratory testing, angiotensin converting enzyme (ACE) inhibitor angioedema, indications for antihistamines and corticosteroids, indications for nasopharyngolaryngoscopy, and patient disposition. (medscape.com)
  • I also struggle with taking my antihistamines daily - I worry that I'm reinforcing the syndrome by taking them and believe me I've tried not to, but well - just google angioedema images and you'll see what I'm up against if I don't take them! (tmswiki.org)
  • In such cases, hereditary and acquired angioedema (AAE) must be differentiated. (medscape.com)
  • Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment. (cooperhealth.org)
  • 5,7 Potentially fatal upper airway angioedema has been reported in patients as young as 3 years of age. (businesswire.com)
  • Randomized trial of icatibant for angiotensin-converting enzyme inhibitor-induced upper airway angioedema. (wayne.edu)
  • Discontinue immediately if symptoms of angioedema such as facial, perioral, or upper airway swelling occur. (nih.gov)
  • For recurrent angioedema without urticaria, it is strongly recommended to rule out hereditary angioedema (HAE), angiotensin-converting enzyme inhibitor induced angioedema (ACEI-AAE, or AIIA), and acquired C1 esterase inhibitor deficiency angioedema (C1-INH-AAE). (medscape.com)
  • Angiotensin-converting enzyme inhibitor-induced small-bowel angioedema: clinical and imaging findings in 20 patients. (medscape.com)
  • Objective Angioedema is a potentially life-threatening complication of angiotensin-converting enzyme inhibitor (ACEI) use, occurring in up to 0.5% of users. (nih.gov)
  • Angioedema may be caused by an allergic reaction . (medlineplus.gov)
  • An allergic reaction can cause angioedema. (aafa.org)
  • Although certain foods and drugs may trigger the angioedema, it is not an allergic reaction to those substances. (merckmanuals.com)
  • Hereditary angioedema and acquired angioedema resemble angioedema caused by an allergic reaction. (msdmanuals.com)
  • Additionally, it is a good thing to keep in mind the pathophysiology when considering therapies for children that have known Hereditary Angioedema (the typical allergic reaction medications won't work). (pedemmorsels.com)
  • In hereditary angioedema, bradykinin formation is caused by continuous activation of the complement system due to a deficiency in one of its prime inhibitors, C1-esterase (aka: C1-inhibitor or C1INH), and continuous production of kallikrein, another process inhibited by C1INH. (wikipedia.org)
  • [ 8 ] Common drugs that cause angioedema include angiotensin-converting enzyme inhibitors, nonsteroidal anti- inflammatory agents, and aspirin. (medscape.com)
  • To determine the incidence of angioedema associated with ACE inhibitors versus placebo in the treatment of primary hypertension. (cochrane.org)
  • Tranexamic acid as first-line emergency treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors. (cooperhealth.org)
  • Boss s expression also changed, as if he Angioedema From Ace Inhibitors realized something. (ytu.edu.mm)
  • The green monkey knew that Kevin was about to leave again, angioedema from ace inhibitors and his figure angioedema from ace inhibitors came to Kevin s shoulder. (ytu.edu.mm)
  • But as a gust of breeze blood pressure measurement when to take medicine blew by, the monster boy s nose angioedema from ace inhibitors twitched a few times, and the next lower body blood pressure moment he turned around, instead of heading directly towards the mountain where the magic spar mine was located. (ytu.edu.mm)
  • But Blood Moon, who knew all of this, was unable to face Boss s son, angioedema from ace inhibitors and said these things to Juewen little by little. (ytu.edu.mm)
  • In today s human angioedema from ace inhibitors world, there is still a scene of celebration in the whole world! (ytu.edu.mm)
  • In short, there is no way for him to go back, and it is because of this that he is so disheartened angioedema from ace inhibitors as he is now. (ytu.edu.mm)
  • And with the help of angioedema from ace inhibitors sushi lower blood pressure potions, magic circles, etc. (ytu.edu.mm)
  • Angioedema From Ace Inhibitors angioedema from ace inhibitors Having said that, Xianyun s expression became serious, showing a thoughtful look. (ytu.edu.mm)
  • If it wasn blood pressure medication and feeling cold lower blood pressure heal eyes t for the great increase in mental strength, at this time, Boss would probably vomit blood and faint Angioedema From Ace Inhibitors again. (ytu.edu.mm)
  • But if you start taking high blood pressure medicine can you eventually get off them he really needs this thing now, and angioedema from ace inhibitors sushi lower blood pressure angioedema from ace inhibitors he just heard a name, That guy Feng Wushuang also wanted it. (ytu.edu.mm)
  • Hereditary angioedema (HAE) is a disease characterized by recurrent episodes (also called attacks) of severe swelling of the skin and mucous membranes. (nih.gov)
  • citation needed] In hereditary angioedema (HAE), often no direct cause is identifiable, although mild trauma, including dental work and other stimuli, can cause attacks. (wikipedia.org)
  • Hereditary angioedema (HAE) is an inherited chronic rare disease characterised by recurrent swelling attacks that are associated with significant physical and psychological burden. (springer.com)
  • Hereditary angioedema (HAE) is characterised by recurrent attacks of localised swelling in the skin and/or mucosa, affecting the extremities, face, gastrointestinal tract and/or larynx [ 1 ]. (springer.com)
  • Hereditary angioedema (HAE) can cause recurrent attacks. (therapeuticresearch.com)
  • It's FDA-approved to treat acute attacks of hereditary angioedema (HAE) in adults. (medicalnewstoday.com)
  • Firazyr is used to treat acute attacks of hereditary angioedema (HAE) in adults. (medicalnewstoday.com)
  • Firazyr is approved for the treatment of acute attacks of hereditary angioedema (HAE) in adults. (medicalnewstoday.com)
  • Authorities in Chile have approved Orladeyo (berotralstat) to prevent swelling attacks in hereditary angioedema (HAE) patients 12 and older, marking the therapy's first marketing authorization in a Latin American country. (angioedemanews.com)
  • Nearly half of hereditary angioedema (HAE) patients in the U.K. are on long-term prophylactic treatment to prevent swelling attacks, with more than 80% keeping a supply of on-demand therapies at home to treat sudden flares. (angioedemanews.com)
  • A pregnant woman with type 3 hereditary angioedema (HAE) had potential swelling attacks effectively controlled during both pregnancy and breastfeeding with the use of subcutaneous or under-the-skin injections of a plasma-derived C1 esterase inhibitor (C1-INH), according to a case report from Spain. (angioedemanews.com)
  • Preventive treatment with Orladeyo (berotralstat) for up to two years led to prolonged periods of no swelling attacks in people with hereditary angioedema (HAE), irrespective of age, gender, or prior preventive treatments, according to a post-hoc analysis of the Phase 2/3 APeX-S trial. (angioedemanews.com)
  • Allergy is very rarely the cause of isolated angioedema (swelling without any other symptoms). (allergy.org.au)
  • Whilst angioedema may be itchy, tingling, or burning, often there are no symptoms other than the discomfort of the swelling. (allergy.org.au)
  • In the product labeling, angioedema is documented as a possible, but rare, ADR, occurring at a rate of 0.1-0.3%, with symptoms usually developing between 10 and 20 days after initiation of the drug. (medscape.com)
  • [ 16 ] Pulmonary symptoms occur in approximately 40% of angioedema cases and include dyspnea, stridor, and respiratory failure. (medscape.com)
  • For allergies that cannot be totally avoided, like dust or pollen, a regular allergy medication may be advisable depending on how often you experience angioedema and how uncomfortable the symptoms are for you. (ihealthdirectory.com)
  • Certain drugs can help relieve symptoms, but if angioedema makes swallowing or breathing difficult, prompt emergency treatment is needed. (merckmanuals.com)
  • She had the impression her symptoms were due to urticaria but since the process affects the subcutaneous tissues (note the upper lip edema), the more likely diagnosis is angioedema and urticaria. (blogspot.com)
  • Bradykinin mediated angioedema may sometimes present with gastrointestinal symptoms alone. (practicalgastro.com)
  • We include a typical example of the situation where a 60 year old woman presented multiple times to the hospital with gastrointestinal (GI) symptoms due to ACE inhibitor associated angioedema superimposed on hereditary angioedema. (practicalgastro.com)
  • A case of acute schistosomiasis was defined as the onset of fever or hypersensitivity symptoms-urticarial rash, angioedema, dry cough or wheeze-after exposure to infected water sources, with subsequent confirmation by serologic or parasitologic testing. (cdc.gov)
  • Various mechanisms that interfere with bradykinin production or degradation can lead to angioedema. (wikipedia.org)
  • There are two main pathways which lead to angioedema: the mast-cell mediated pathway and the bradykinin-mediated pathway. (cooperhealth.org)
  • Urticaria and angioedema. (medlineplus.gov)
  • Marx J, Hockberger R, Walls R. Urticaria and angioedema. (medscape.com)
  • A MEDLINE search for articles published between January 1996 and April 2006 was performed for urticaria and angioedema. (medscape.com)
  • With the exception of hereditary angioedema, routine laboratory studies such as a complete blood count, basic metabolic panel, electrolytes, liver function tests, or urinalysis have been shown to be of no utility in the evaluation of acute urticaria and angioedema. (medscape.com)
  • In order to provide effective and efficient care, it is imperative to understand current concepts and controversies in the management of urticaria and angioedema. (medscape.com)
  • Angioedema is an area of swelling (edema) of the lower layer of skin and tissue just under the skin or mucous membranes. (wikipedia.org)
  • Angioedema is nonpitting edema of the deep dermal and subcutaneous tissues. (medscape.com)
  • Dr Heinrich Quincke first described the clinical picture of angioedema in 1882, hence the eponym Quincke's edema. (blogspot.com)
  • As a recognized rare and highly fatal disease, hereditary angioedema (HAE) is difficult to diagnose and characterized by recurrent edema involving the head , limbs , genitals and larynx , etc. (bvsalud.org)
  • Special consideration should be given to those who experience angioedema without urticaria. (medscape.com)
  • Where does angioedema occur? (allergy.org.au)
  • Allergic causes for isolated angioedema are rare but should be suspected with short-lived episodes of swelling that occur under similar situations, such as after taking certain foods or medicinations. (allergy.org.au)
  • A common location where angioedema can occur is around the eyes, lips, and face. (aafa.org)
  • Angioedema can also occur on other parts of the body, even in the throat. (aafa.org)
  • People with recurrent angioedema should be referred by their doctor to a clinical immunology/allergy specialist to investigate for an underlying cause and optimise treatment. (allergy.org.au)
  • Clinical management of patients with a history of urticaria/angioedema induced by multiple NSAIDs: an expert panel review. (medscape.com)
  • This clinical guideline is intended for patients presenting with a chief complaint of acute urticaria and/or angioedema. (medscape.com)
  • This clinical guideline focuses on the evaluation and treatment of emergency department patients with acute urticaria and/or angioedema. (medscape.com)
  • Clinical features of pediatric hereditary angioedema. (pedemmorsels.com)
  • An experimental gene-editing therapy for hereditary angioedema (HAE), called NTLA-2002, has been administered to the first participant in the Phase 2 portion of a clinical trial, according to its developer, Intellia Therapeutics. (angioedemanews.com)
  • The bradykinin-mediated pathway is subdivided into ACE-inhibitor induced, hereditary angioedema and idiopathic angioedema. (cooperhealth.org)
  • Efficacy of tranexamic acid in sporadic idiopathic bradykinin angioedema. (cooperhealth.org)
  • Certainly we will encounter many more cases of chronic recurrent abdominal pain that are due to idiopathic or benign entities , but keeping Hereditary Angioedema on our differential will allow us look for the clues that may help positively impact that child's life. (pedemmorsels.com)
  • Background: Angioedema (AE) is idiopathic in the majority of cases. (cdc.gov)
  • In the remaining 102 (63%) patients the cause of angioedema was idiopathic. (cdc.gov)
  • Risk factors include atopy, history of angioedema, chronic urticaria, history of smoking, African-American race, and recent initiation of medication or dose increase. (medscape.com)
  • Angioedema may be acute or chronic. (msdmanuals.com)
  • Angioedema can be chronic, recurring over weeks or months. (msdmanuals.com)
  • Comparison with oral tranexamic acid may be flawed as it is not the 'gold standard' treatment for acute exacerbation of hereditary angioedema. (bestbets.org)
  • Acute angioedema develops suddenly after exposure to a trigger. (msdmanuals.com)
  • Severe throat swelling requires early use of medication such as adrenaline for anaphylaxis or icatibant for hereditary angioedema (HAE), and transfer to hospital by ambulance. (allergy.org.au)
  • BestBets: Management of adult patients with Icatibant in hereditary angioedema. (bestbets.org)
  • When angioedema is associated with urticaria, the diagnostic algorithm is almost identical to that of urticaria patients. (medscape.com)
  • [ 14 ] Therefore, for angioedema without urticaria, and once C1 INH deficiency and ACEI-AAE are ruled out, empirical treatment with high doses of a second generation antihistamine (up to 4 times more than the conventional dose) can help further categorize the patients (histaminergic vs. nonhistaminergic). (medscape.com)
  • Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients. (medscape.com)
  • 56 known adult HAE patients (type I and II) in the For Angioedema Subcutaneous Treatment (FAST-1) trial (USA). (bestbets.org)
  • Today's approval for TAKHZYRO in pediatric patients as young as 2 years of age brings a welcome and important addition to treatment options available for children living with HAE," said Anthony Castaldo, president and CEO of the U.S. Hereditary Angioedema Association (HAEA). (businesswire.com)
  • Patients with acquired angioedema have low C1q levels AND low C4/C2 levels. (blogspot.com)
  • Methods: In X‐ACT, a phase III, double‐blind, placebo‐controlled study, CSU patients (18‐75 years) with ≥4 angioedema episodes during the 6 months before inclusion were randomized (1:1) to receive omalizumab 300 mg or placebo every 4 weeks for 28 weeks. (fu-berlin.de)
  • Conclusions: Our findings support omalizumab treatment in patients with severe H1‐antihistamine‐refractory CSU with angioedema. (fu-berlin.de)
  • For emergency physicians, the evaluation and management of patients with urticaria or angioedema can be challenging. (medscape.com)
  • Hereditary angioedema is episodic and asymptomatic in most patients. (lu.se)
  • Perioperative Management of Patients With Hereditary Angioedema With Special Considerations for Cardiopulmonary Bypass. (ouhsc.edu)
  • Diagnosis and treatment procedures and health management for patients with hereditary angioedema]. (bvsalud.org)
  • Examination of genetic variants involved in generation and biodisposition of kinins in patients with angioedema. (cdc.gov)
  • RÉSUMÉ Nous avions l'objectif d'étudier la prévalence des effets secondaires causés par les statines chez des patients iraniens admis dans un hôpital spécialisé en cardiologie et sous traitement par statines avant leur hospitalisation. (who.int)
  • This new finding together with her strong family history of angioedema and her recurrent episodes while on Lisinopril led to the diagnosis of ACE inhibitor associated angioedema superimposed on hereditary angioedema. (practicalgastro.com)
  • Angioedema of the throat can cause breathing difficulty. (aafa.org)
  • Angioedema of the throat is an allergic emergency . (aafa.org)
  • There are occasions where the angioedema can be severe or affect the tongue, throat or lungs, thus hindering respiration. (ihealthdirectory.com)
  • Angioedema is swelling of areas of tissue under the skin, sometimes affecting the face and throat. (msdmanuals.com)
  • [ 11 ] The most important step in the treatment of drug-induced angioedema is discontinuation of the offending drug. (medscape.com)
  • Raman SP, Lehnert BE, Pruthi S. Unusual radiographic appearance of drug-induced pharyngeal angioedema and differential considerations. (medscape.com)
  • Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. (medscape.com)
  • Angioedema in the emergency department: a practical guide to differential diagnosis and management. (cooperhealth.org)
  • Computed tomography of the gastrointestinal manifestation of hereditary angioedema. (medscape.com)
  • Gastrointestinal: angioedema of the small bowel. (medscape.com)
  • In this article, we aim to heighten the awareness of intestinal angioedema among gastroenterologists as well as help differentiate it from other more common similar gastrointestinal conditions. (practicalgastro.com)
  • Rye Rasmussen EH, Bindslev-Jensen C, Bygum A. Angioedema--assessment and treatment. (medscape.com)
  • Conclusion The efficacy of treatment of ACEI-induced angioedema with bradykinin antagonists, kallikrein inhibitor, and C1 inhibitor warrants further study. (nih.gov)
  • Efficacy of treatment of non-hereditary angioedema. (cooperhealth.org)
  • Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. (cooperhealth.org)
  • 1. Longhurst HJ, Bork K. Hereditary angioedema: causes, manifestations and treatment. (conhecaaeh.com.br)
  • Hereditary Angioedema (HAE) is a rare genetic condition. (aaaai.org)
  • Hereditary angioedema is a potentially life-threatening disorder caused by a genetic defect. (aaaai.org)
  • Hereditary angioedema (a genetic disorder) and acquired angioedema (acquired C1 inhibitor deficiency) are caused by a deficiency or malfunction of C1 inhibitor, which is part of the immune system. (merckmanuals.com)
  • Hereditary angioedema is a genetic disorder that causes a deficiency or malfunction of C1 inhibitor. (merckmanuals.com)
  • Angioedema alone: itchy, hot and red swellings, often large and uncomfortable. (allergy.org.au)
  • Angioedema that does not affect the breathing may be uncomfortable. (medlineplus.gov)
  • Allergy tests can be useful for this type of reaction, but it is important to note that food allergy is a very rare cause for isolated angioedema. (allergy.org.au)
  • Angioedema is seldom caused by a serious underlying disease, nor does it make you sick or cause damage to organs such as kidneys, liver or lungs. (allergy.org.au)
  • Angioedema does not damage internal organs like kidneys, liver or lungs. (allergy.org.au)
  • Jennifer, Angioedema does not usually affect the lungs. (blogspot.com)
  • Angioedema does not affect the lungs - it's a skin/mucosal condition. (blogspot.com)
  • Angioedema involves swelling deeper in the tissues. (allergy.org.au)
  • The deeper swelling of angioedema may also be painful. (medlineplus.gov)
  • Angioedema is a condition that causes leakage of blood vessels resulting in the swelling of deeper layers of the skin, subcutaneous and submucosal tissues. (medindia.net)
  • The HAEA continues to actively support all types of novel HAE research, particularly through the US HAEA Angioedema Center at UCSD. (haea.org)
  • Most clinicians are familiar with angioedema involving the face and the upper respiratory airways. (practicalgastro.com)
  • Angioedema " refers to swelling that occurs deep within your skin's inner layers. (medicalnewstoday.com)